We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$773M
AUM Growth
-$71.9M
Cap. Flow
-$78.8M
Cap. Flow %
-10.19%
Top 10 Hldgs %
77.44%
Holding
144
New
42
Increased
11
Reduced
17
Closed
69

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$11.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$10.8M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10.8M
4
ARES icon
Ares Management
ARES
+$10.2M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$10.2M

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.4M
2
SN icon
SharkNinja
SN
+$14.8M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$11.2M
4
ODD icon
ODDITY Tech
ODD
+$8.91M
5
GE icon
GE Aerospace
GE
+$8.43M

Sector Composition

Rank Sector Weight
1 Healthcare 6.59%
2 Technology 4.5%
3 Industrials 3.66%
4 Financials 3.35%
5 Consumer Discretionary 2.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADCT icon
76
ADC Therapeutics
ADCT
$144M
– –
-500,000
Closed -$2.25M
ADT icon
77
ADT
ADT
$5.58B
– –
-320,000
Closed -$2.15M
AQST icon
78
Aquestive Therapeutics
AQST
$494M
– –
-1,000,000
Closed -$4.26M
ARQT icon
79
Arcutis Biotherapeutics
ARQT
$3.18B
– –
-380,000
Closed -$3.77M
ATMU icon
80
Atmus Filtration Technologies
ATMU
$4.18B
– –
-100,000
Closed -$3.23M
AUTL
81
Autolus Therapeutics
AUTL
$562M
– –
-492,000
Closed -$3.14M
BBIO icon
82
BridgeBio Pharma
BBIO
$16.5B
– –
-60,000
Closed -$1.86M
BILI icon
83
Bilibili
BILI
$7.84B
– –
-175,000
Closed -$1.96M
BROS icon
84
Dutch Bros
BROS
$9.26B
– –
-50,000
Closed -$1.65M
BUD icon
85
AB InBev
BUD
$165B
– –
-270,100
Closed -$16.4M
BWMN icon
86
Bowman Consulting
BWMN
$477M
– –
-25,000
Closed -$870K
CDLX icon
87
Cardlytics
CDLX
$21.5M
– –
-7,500
Closed -$1.09M
CDRE icon
88
Cadre Holdings
CDRE
$1.41B
– –
-60,000
Closed -$2.17M
CGON icon
89
CG Oncology
CGON
$6.66B
– –
-125,000
Closed -$5.49M
CHWY icon
90
Chewy
CHWY
$9.63B
– –
-200,000
Closed -$3.18M
CLDX icon
91
Celldex Therapeutics
CLDX
$3.28B
– –
-87,500
Closed -$3.67M
DT icon
92
Dynatrace
DT
$14.2B
– –
-35,000
Closed -$1.63M
EOLS icon
93
Evolus
EOLS
$501M
– –
-150,000
Closed -$2.1M
EPRT icon
94
Essential Properties Realty Trust
EPRT
$6.62B
– –
-125,000
Closed -$3.33M
EYPT icon
95
EyePoint Inc
EYPT
$1.2B
– –
-100,000
Closed -$2.07M
FSBC icon
96
Five Star Bancorp
FSBC
$1.13B
– –
-25,000
Closed -$563K
GE icon
97
GE Aerospace
GE
$384B
– –
-60,144
Closed -$8.43M
GEHC icon
98
GE HealthCare
GEHC
$32.4B
– –
-30,000
Closed -$2.73M
HOWL icon
99
Werewolf Therapeutics
HOWL
$19.3M
– –
-890,000
Closed -$5.77M
ICHR icon
100
Ichor Holdings
ICHR
$2.56B
– –
-122,960
Closed -$4.75M
2 3
4
5 6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Monashee Investment Management held 144 positions worth $773M, down 8.5% from $845M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Monashee Investment Management withdrew a net $78.8M in Q2 2024, closing 69 positions and reducing 17 holdings. Its most notable exit was AB InBev, an estimated $16.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Monashee Investment Management opened a new position in Ares Management worth $10M.

  • Monashee Investment Management's largest Q2 2024 buy was Ares Management: 75,000 shares worth $10M.
  • Monashee Investment Management added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $11.8M increase.
  • Monashee Investment Management's biggest Q2 2024 reduction was REV Group, cutting an estimated $4.76M.
  • Monashee Investment Management fully exited AB InBev in Q2 2024, selling an estimated $16.4M.
  • Monashee Investment Management's ten largest holdings make up 77% of its $773M portfolio in Q2 2024.
  • Monashee Investment Management opened 42 new positions and closed 69 in Q2 2024.
  • Monashee Investment Management's portfolio value fell 8.5% quarter-over-quarter to $773M.

Based on Monashee Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.